Prophylactic treatment with paroxetine ameliorates behavioral deficits and retards the development of amyloid and tau pathologies in 3xTgAD mice
Data up to Jan 2025
Total Citations Per Year
Abstract
References (107)
A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding
1976 • 225,752 citations
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 • 10,051 citations
Mild cognitive impairment as a diagnostic entity
2004 • 7,048 citations
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
1996 • 4,118 citations
Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles
2003 • 3,802 citations
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
1998 • 3,404 citations
Pathways towards and away from Alzheimer's disease
2004 • 2,936 citations
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
1992 • 2,520 citations
Amyloid deposition as the central event in the aetiology of Alzheimer's disease
1991 • 2,375 citations
Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
2002 • 1,912 citations
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
2004 • 1,637 citations
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
2000 • 1,498 citations
Depression and Risk for Alzheimer Disease
2006 • 1,348 citations
Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline
2000 • 1,259 citations
Intraneuronal Aβ Causes the Onset of Early Alzheimer’s Disease-Related Cognitive Deficits in Transgenic Mice
2005 • 1,206 citations
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus
1996 • 1,200 citations
Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex
2003 • 933 citations
Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
2004 • 928 citations
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
2003 • 928 citations
Molecular and Neuronal Substrate for the Selective Attenuation of Anxiety
2000 • 927 citations
BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders
2004 • 893 citations
BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease
1991 • 887 citations
Environmental Enrichment Reduces Aβ Levels and Amyloid Deposition in Transgenic Mice
2005 • 859 citations
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
2003 • 811 citations
Essential Role for TrkB Receptors in Hippocampus-Mediated Learning
1999 • 797 citations
Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective
1999 • 733 citations
Individual Differences in Trait Anxiety Predict the Response of the Basolateral Amygdala to Unconsciously Processed Fearful Faces
2004 • 674 citations
The Use of the Morris Water Maze in the Study of Memory and Learning
1989 • 665 citations
Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer's disease
2005 • 649 citations
Positron emission tomography in Alzheimer's disease
1986 • 563 citations
E<scp>PIDEMIOLOGY OF</scp>N<scp>EURODEGENERATION</scp>
2003 • 513 citations
Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling
2002 • 508 citations
cAMP Response Element-Mediated Gene Transcription Is Upregulated by Chronic Antidepressant Treatment
2000 • 503 citations
Region-Specific Neurotrophin Imbalances in Alzheimer Disease
2000 • 499 citations
Serotonin in Aging, Late-Life Depression, and Alzheimer's Disease: The Emerging Role of Functional Imaging
1998 • 493 citations
Neocortical Neurofibrillary Tangles Correlate With Dementia Severity in Alzheimer's Disease
1995 • 488 citations
Acetylcholine modulation of neural systems involved in learning and memory
2003 • 440 citations
Reversible Memory Loss in a Mouse Transgenic Model of Alzheimer's Disease
2002 • 423 citations
Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice
2003 • 417 citations
NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults
1994 • 402 citations
BDNF and Full-length and Truncated TrkB Expression in Alzheimer Disease. Implications in Therapeutic Strategies
1999 • 387 citations
Cortical abnormalities in Alzheimer's disease
1984 • 378 citations
Temporal Profile of Amyloid-β (Aβ) Oligomerization in an in Vivo Model of Alzheimer Disease
2005 • 370 citations
New Phosphorylation Sites Identified in Hyperphosphorylated Tau (Paired Helical Filament‐Tau) from Alzheimer's Disease Brain Using Nanoelectrospray Mass Spectrometry
1998 • 364 citations
Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF
2004 • 318 citations
Caloric restriction attenuates Aβ-deposition in Alzheimer transgenic models
2004 • 318 citations
Hippocampal innervation by serotonin neurons of the midbrain raphe in the rat
1975 • 310 citations
Caloric restriction attenuates β‐amyloid neuropathology in a mouse model of Alzheimer's disease
2005 • 306 citations
Testosterone reduces neuronal secretion of Alzheimer's β-amyloid peptides
2000 • 292 citations
Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice
2003 • 282 citations
Relative Roles of Plaques and Tangles in the Dementia of Alzheimer's Disease: Correlations Using Three Sets of Neuropathological Criteria
1995 • 281 citations
Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder
2000 • 259 citations
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors
2004 • 256 citations
Bi-phasic change in BDNF gene expression following antidepressant drug treatment
2003 • 244 citations
Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice
2001 • 229 citations
Learning upregulates brain-derived neurotrophic factor messenger ribonucleic acid: A mechanism to facilitate encoding and circuit maintenance?
1998 • 228 citations
Learning and Memory in Transgenic Mice Modeling Alzheimer's Disease
2001 • 224 citations
Progressive and gender-dependent cognitive impairment in the APPSW transgenic mouse model for Alzheimer’s disease
1999 • 221 citations
β-Amyloid-(1–42) Impairs Activity-dependent cAMP-response Element-binding Protein Signaling in Neurons at Concentrations in Which Cell Survival Is Not Compromised
2001 • 211 citations
Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice
2001 • 199 citations
Emotional Memory: In Search of Systems and Synapsesa
1993 • 189 citations
Reversal of Behavioral and Metabolic Abnormalities, and Insulin Resistance Syndrome, by Dietary Restriction in Mice Deficient in Brain-Derived Neurotrophic Factor
2003 • 179 citations
Tau gene mutations: dissecting the pathogenesis of FTDP-17
2002 • 174 citations
Specific spatial learning deficits become severe with age in β-amyloid precursor protein transgenic mice that harbor diffuse β-amyloid deposits but do not form plaques
2001 • 162 citations
Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant
2003 • 157 citations
Mechanism of Cerebral β-Amyloid Angiopathy: Murine and Cellular Models
2006 • 148 citations
Influence of Paroxetine, Branched-Chain Amino Acids and Tyrosine on Neuroendocrine System Responses and Fatigue in Humans
1998 • 140 citations
Amygdala Volume Reductions in Pediatric Patients with Obsessive–Compulsive Disorder Treated with Paroxetine: Preliminary Findings
2004 • 140 citations
Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety
2004 • 129 citations
Does my mouse have Alzheimer's disease?
2002 • 129 citations
Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms
2005 • 121 citations
Estrogen induces a rapid secretion of amyloid β precursor protein via the mitogen‐activated protein kinase pathway
2001 • 118 citations
Neurofibrillary tangles and β-amyloid deposits in Alzheimer's disease
1991 • 116 citations
Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels
2006 • 112 citations
Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease
1994 • 111 citations
Interactions of Amyloidogenic Proteins
2003 • 111 citations
Brain-derived neurotrophic factor, behavior, and new directions for the treatment of mental disorders
2003 • 110 citations
Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: A single-blind randomised placebo controlled trial
2003 • 105 citations
The mechanisms involved in the long‐lasting neuroprotective effect of fluoxetine against MDMA (‘ecstasy’)‐induced degeneration of 5‐HT nerve endings in rat brain
2001 • 105 citations
Seizure-induced memory impairment is reduced by choline supplementation before or after status epilepticus
2002 • 103 citations
Serotonin laterality in amygdala predicts performance in the elevated plus maze in rats
1999 • 96 citations
Amygdala cell loss and atrophy in Alzheimer's disease
1992 • 94 citations
Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: Implications for Alzheimer β-amyloid pathology
2006 • 94 citations
Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment
2005 • 92 citations
Paroxetine retards disease onset and progression in Huntingtin mutant mice
2004 • 91 citations
Development of Aβ terminal end-specific antibodies and sensitive ELISA for Aβ variant
2004 • 81 citations
Sex differences in serotonergic activity in dorsal and median raphe nucleus
2003 • 70 citations
Functional Neurochemistry of Alzheimers Disease
2004 • 65 citations
Behavioral and psychological symptoms of dementia characteristic of mild Alzheimer patients
2005 • 62 citations
Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine
2002 • 62 citations
GABA-A and 5-HT1A Receptor Agonists Block Expression of Fear-Potentiated Startle in Mice
2002 • 57 citations
Affinity Purification of Human τ Proteins and the Construction of a Sensitive Sandwich Enzyme‐Linked Immunosorbent Assay for Human τ Detection
1992 • 48 citations
FDA-Preapproved Drugs Targeted to the Translational Regulation and Processing of the Amyloid Precursor Protein
2004 • 46 citations
Disturbance of the 5-hydroxytryptamine metabolism in brains from patients with Alzheimer’s dementia
1990 • 42 citations
Pilot Study of the Reducing Effect on Amyloidosis In Vivo by Three FDA Pre-Approved Drugs Via the Alzheimers APP 5Untranslated Region
2005 • 41 citations
Toward Alzheimer Therapies Based on Genetic Knowledge
2004 • 40 citations
Spotlight on Paroxetine in Psychiatric Disorders in Adults*
2002 • 31 citations
Restraint stress induces β-amyloid precursor protein mRNA expression in the rat basolateral amygdala
2004 • 25 citations
Effect of LTP-reinforcing paradigms on neurotransmitter release in the dentate gyrus of young and aged rats
2004 • 25 citations
Evaluation of [3H]paroxetine as an in vivo ligand for serotonin uptake sites: A quantitative autoradiographic study in the rat brain
1993 • 24 citations
Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review
2002 • 23 citations
Influence of fluoxetine and paroxetine in behavioral sensitization induced by ethanol in mice
2005 • 20 citations
The amygdala in down's syndrome and familial Alzheimer's disease: Four clinicopathological case report
1991 • 19 citations
Laterality in the Histological Effects of Injections of Amyloid-β 25-35 into the Amygdala of Young Fischer Rats
1997 • 17 citations
Alzheimer's disease: From molecular biology to neuropsychiatry
2003 • 13 citations
Clinical and Molecular Aspects of Frontotemporal Dementia
2004 • 10 citations
Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
1998 • 8 citations